Novotech extends arms into US with acquisition of a South Carolina CRO

Josh Sullivan

The Singapore-based CRO Novotech has acquired NCGS to expand its global offerings for clients, and finally offer its full-service high-quality clinical services to customers in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novotech extends arms into US with acquisition of a South Carolina CRO

Josh Sullivan

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Judge halts some NIH cuts after 22 states sue

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma

Eli Lilly inks $630M deal for Phase 1 MASH candidate

Boehringer Ingelheim touts success in second Phase 3 lung fibrosis trial

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

Novotech ex­tends arms in­to US with ac­qui­si­tion of a South Car­oli­na CRO

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Novotech extends arms into US with acquisition of a South Carolina CRO